Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
72,47 USD | -0,07% | -10,93% | +1,47% |
Omzet 2024 * | 137 mln. 129 mln. | Omzet 2025 * | 158 mln. 148 mln. | Marktkapitalisatie | 1,28 mld. 1,2 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 28 mln. 26,28 mln. | Nettowinst (verlies) 2025 * | 52 mln. 48,81 mln. | EV/omzet 2024 * | 9,34 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 8,14 x |
K/w-verhouding 2024 * |
43,3
x | K/w-verhouding 2025 * |
25,3
x | Werknemers | 58 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,07% |
Recentste transcriptie over Ligand Pharmaceuticals Incorporated
1 dag | -0,07% | ||
1 week | -10,93% | ||
Lopende maand | -0,86% | ||
1 maand | +0,36% | ||
3 maanden | -0,07% | ||
6 maanden | +37,31% | ||
Lopend jaar | +1,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 63 | 01-03-07 |
Octavio Espinoza
DFI | Director of Finance/CFO | 53 | 01-11-22 |
President | 49 | 06-08-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John W. Kozarich
CHM | Chairman | 74 | 01-03-03 |
John LaMattina
BRD | Director/Board Member | 74 | 01-02-11 |
Stephen Sabba
BRD | Director/Board Member | 64 | 04-08-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.24% | 27 M€ | -5,75% | - | |
0.14% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 72,47 | -0,07% | 137 196 |
18-04-24 | 72,52 | -8,05% | 131 220 |
17-04-24 | 78,87 | -1,31% | 179 844 |
16-04-24 | 79,92 | +0,19% | 158 485 |
15-04-24 | 79,77 | -1,95% | 175 640 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,47% | 1,28 mld. | |
+24,60% | 654 mld. | |
+24,08% | 552 mld. | |
-5,63% | 356 mld. | |
+15,37% | 319 mld. | |
+7,38% | 295 mld. | |
+3,26% | 211 mld. | |
+0,78% | 206 mld. | |
-9,69% | 147 mld. | |
-6,63% | 144 mld. |